检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:肖婧[1] 闫涵[1] 俞静[1] 杨薏帆[1] 曹邦伟[1]
机构地区:[1]北京首都医科大学附属北京友谊医院肿瘤科,北京100050
出 处:《中国现代医学杂志》2015年第15期11-16,共6页China Journal of Modern Medicine
基 金:北京市卫生系统高层次卫生技术人才资助项目(No:2011-3-007);国家重点基础研究发展计划(973计划)资助项目(No:2012CB526600);消化疾病癌前病变北京市重点实验室基金资助项目(No:2013-2014)
摘 要:目的 评价中国人群中金属基质蛋白酶-7(MMP-7)基因的表达改变与食管癌临床特征间的关系。方法 在Pubmed、CNKI及万方数据库中检索相关的文章,并进行筛选;应用Revman 5.0软件进行统计学分析。结果 共纳入11篇文献,结果显示:在中国人群中,MMP-7阳性表达对于食管癌组织分化程度的OR赞值为2.13(95%CI:1.50~3.04);对于食管癌淋巴结转移的OR赞值为3.25(95%CI:2.29~4.62);对于食管癌组织浸润深度的OR赞值为3.45(95%CI:2.36~5.03);对于食管癌临床分期的OR赞值为3.71(95%CI:2.57~5.36)。而在亚组分析中也显示MMP-7阳性表达与食管癌的不良预后风险存在着一定的联系。结论 中国人群中MMP-7基因的阳性表达与食管癌的组织分化程度、浸润深度、淋巴结转移及临床分期有关,可能是其不良的预后标志物。[ Objective ] To evaluate the relationship between matrix metalloproteinase-7(MMP-7) gene expression and clinical characters of esophageal cancer among Chinese people. [ Methods ] Articles about the clinical roles of MMP-7 in esophageal cancer were searched through PubMed, CNKI and Wanfang databases. The data were ana- lyzed by the software Revman 5.0. [ Results ] Totally 11 articles were recruited in our system assessment. The results of this system assessment showed that the OR value of MMP-7 expression's influence on the differentiation degree, lymphatic metastasis, depth of invasion and cancer staging of esophageal cancer was 2.13 (95%CI: 1.50~3.04), 3.25 (95%CI: 2.29~4.62), 3.45 (95%CI: 2.36~5.03) and 3.71 (95%CI: 2.57~5.36), respectively. The relationship between positive MMP-7 expression and poor prognosis of esophageal cancer was also observed in the subgroup analysis. [ Conclusions ] MMP-7 has played a great role in the differentiation degree, lymphatic metastasis, depth of invasion and the staging of esophageal cancer among Chinese people, which may indicate the poor prognosis.
关 键 词:食管癌 临床特征 金属基质蛋白酶-7基因 系统评价
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.112